PERCEPTIVE ADVISORS LLC Q2 2021 Filing
Filed August 16, 2021
Portfolio Value
$7.7B
Holdings
148
Report Date
Q2 2021
Filing Type
13F-HR
All Holdings (148 positions)
| Stock | Value |
|---|---|
MRTXEURMIRATI THERAPEUTICS INC | $514.6M |
BBIOBRIDGEBIO PHARMA INC | $472.9M |
SWTXSPRINGWORKS THERAPEUTICS INC | $399.7M |
TVTX 2.5 09/15/25RETROPHIN INC | $384.4M |
IOVAIOVANCE BIOTHERAPEUTICS INC | $285.2M |
AM6AMICUS THERAPEUTICS INC | $222.9M |
—COLLEGIUM PHARMACEUTICAL INC | $189.7M |
HZNPHORIZON THERAPEUTICS PUB L | $185.9M |
VAC2USDVBI VACCINES INC CDA | $184.4M |
—LANDOS BIOPHARMA INC | $171.7M |
NVTA1EURINVITAE CORP | $162.5M |
NVRO 2.75 04/01/25NEVRO CORP | $156.3M |
—ZYMEWORKS INC | $149.4M |
GBTUSDGLOBAL BLOOD THERAPEUTICS IN | $145.4M |
NVROEURNEVRO CORP | $135.7M |
RCKTROCKET PHARMACEUTICALS INC | $121.9M |
OMGBPOUTSET MED INC | $119.3M |
CERE1EURCEREVEL THERAPEUTICS HLDNG I | $119.0M |
ALDXALDEYRA THERAPEUTICS INC | $112.2M |
UTHUNITED THERAPEUTICS CORP DEL | $110.7M |
MGTXMEIRAGTX HLDGS PLC | $107.7M |
NAUTNAUTILUS BIOTECHNOLOGY INC | $90.0M |
CCCCC4 THERAPEUTICS INC | $85.5M |
—SINGULAR GENOMICS SYSTEMS IN | $84.7M |
BDQMALBIREO PHARMA INC | $83.0M |
—PROMETHEUS BIOSCIENCES INC | $81.4M |
NBIXNEUROCRINE BIOSCIENCES INC | $79.0M |
RAPTEURRAPT THERAPEUTICS INC | $78.8M |
CRNXCRINETICS PHARMACEUTICALS IN | $74.7M |
RLAYRELAY THERAPEUTICS INC | $73.8M |
BEAMBEAM THERAPEUTICS INC | $69.2M |
—ZYMERGEN INC | $65.3M |
CHRSCOHERUS BIOSCIENCES INC | $65.0M |
ATNXEURATHENEX INC | $62.5M |
ESTAESTABLISHMENT LABS HLDGS INC | $61.2M |
—KADMON HLDGS INC | $60.8M |
KRON1USDKRONOS BIO INC | $60.5M |
—QUOTIENT LTD | $59.0M |
MGNXMACROGENICS INC | $57.7M |
MDTMEDTRONIC PLC | $55.9M |
MORFMORPHIC HLDG INC | $53.8M |
SLDBSOLID BIOSCIENCES INC | $49.1M |
AVIRATEA PHARMACEUTICALS INC | $48.5M |
—COHERUS BIOSCIENCES INC | $46.1M |
—CAREMAX INC | $42.8M |
—DBV TECHNOLOGIES S A | $42.0M |
APLSAPELLIS PHARMACEUTICALS INC | $41.8M |
VRCAVERRICA PHARMACEUTICALS INC | $40.8M |
—RAIN THERAPEUTICS INC | $39.4M |
TMCITREACE MED CONCEPTS INC | $38.6M |
TARSTARSUS PHARMACEUTICALS INC | $37.6M |
AXSMAXSOME THERAPEUTICS INC | $37.4M |
VERUEURVERU INC | $35.9M |
—ATHIRA PHARMA INC | $35.1M |
HCATHEALTH CATALYST INC | $31.4M |
XENEXENON PHARMACEUTICALS INC | $31.3M |
—DICERNA PHARMACEUTICALS INC | $29.9M |
BCABBIOATLA INC | $29.1M |
EXASEXACT SCIENCES CORP | $29.0M |
IMTXIMMATICS N.V | $29.0M |
NARIUSDINARI MED INC | $29.0M |
OPHTEURIVERIC BIO INC | $28.9M |
XLRNACCELERON PHARMA INC | $28.5M |
NUVBNUVATION BIO INC | $28.3M |
ATECALPHATEC HLDGS INC | $27.6M |
TVTXTRAVERE THERAPEUTICS INC | $26.9M |
GRPHGRAPHITE BIO INC | $26.9M |
RNAAVIDITY BIOSCIENCES INC | $26.7M |
KODKODIAK SCIENCES INC | $26.6M |
ADMAADMA BIOLOGICS INC | $26.5M |
RGENREPLIGEN CORP | $26.4M |
ARWRARROWHEAD PHARMACEUTICALS IN | $26.1M |
LYRALYRA THERAPEUTICS INC | $25.9M |
COGTCOGENT BIOSCIENCES INC | $25.9M |
PMVPPMV PHARMACEUTICALS INC | $25.5M |
INBXUSDINHIBRX INC | $25.0M |
TCE2CELLDEX THERAPEUTICS INC NEW | $24.8M |
COLLCOLLEGIUM PHARMACEUTICAL INC | $23.1M |
TOCAEURFORTE BIOSCIENCES INC | $23.0M |
STOKSTOKE THERAPEUTICS INC | $22.6M |
—AGILE THERAPEUTICS INC | $21.2M |
MNLOUSDVYNE THERAPEUTICS INC | $20.3M |
—ONCORUS INC | $20.2M |
CLOVCLOVER HEALTH INVESTMENTS CO | $20.0M |
VRNAVERONA PHARMA PLC | $18.9M |
DAWNDAY ONE BIOPHARMACEUTICALS I | $17.2M |
—1LIFE HEALTHCARE INC | $17.1M |
—CM LIFE SCIENCES II INC | $16.8M |
TDOCTELADOC HEALTH INC | $16.6M |
—CATABASIS PHARMACEUTICALS IN | $16.2M |
NSTG 2.625 03/01/25NANOSTRING TECHNOLOGIES INC | $16.2M |
IMCRIMMUNOCORE HLDGS PLC | $15.6M |
—NEPTUNE WELLNESS SOLUTIONS I | $15.0M |
ACRSACLARIS THERAPEUTICS INC | $14.9M |
—HEALTHCOR CATALIO ACQU CORP | $14.8M |
NBTXNANOBIOTIX SA | $14.6M |
VRDNVIRIDIAN THERAPEUTICS INC | $14.5M |
ADPTADAPTIVE BIOTECHNOLOGIES COR | $14.4M |
VTRSVIATRIS INC | $14.4M |
—FUSION PHARMACEUTICALS INC | $14.3M |
Page 1 of 2Next